Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ELRIG Announces Drug Discovery 2013 Preliminary Programme and Call for Posters

Published: Thursday, May 02, 2013
Last Updated: Thursday, May 02, 2013
Bookmark and Share
The 7th Annual Drug Discovery Conference is anticipated to attract over 1000 delegates, engaging scientists involved in early stage drug discovery.

The 2013 programme will contain scientific presentations, an exhibition area with over 100 vendor booths, a networking event, poster sessions, Innovation Zone, Media Area and Careers Zone. Registration for the event is free, and delegates can register online at www.elrig.org.

The scientific sessions will feature presentations from leading scientists, including the show keynote address from Dr Ruth McKernan, CSO of Pfizer’s Neusentis Unit, on ‘Practical applications of stem cell-derived cells within drug discovery’. The eight scientific sessions are:

• Target & Biomarker Identification & Validation
• Advanced Cell Technologies
In vitro DMPK & Safety Screening
• Macromolecules as Therapeutics
• Innovations in Assay Development & Screening
• Science Led sample Management – putting the horse before the cart
• Oncology Drug Targets – where next?
• Macromolecules as Tools for Discovery & Target Validation

ELRIG is calling for poster abstract submissions, which should be sent to posters@elrig.org. This year a subset of poster abstracts will be selected for 10 minute oral presentations, to be given within the main symposia sessions. Delegates will be given the chance to vote for the best poster, with a prize for the poster receiving the highest number of votes.

In collaboration with SLAS (Society for Laboratory Automation and Screening), students, graduates and post-docs are again invited to submit a poster for entry into the Young Scientist Award, the winner of which will receive a $500 cash prize, as well as an expenses-paid trip to present and participate in the Student Poster Competition at SLAS2014, 18-22 January 2014 in San Diego, CA.

Following on from the success of last year’s Dragons Den,this will also be a feature of the 2013 event.  Companies are encouraged to come forward to pitch to the panel of ‘Dragons’.  To find out more please contact Adrian Kinkaid: adrian.kinkaid@elrig.org.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ELRIG Announces Drug Discovery 2012 Keynotes and Workshops
European Laboratory Robotics Interest Group have announced details of the keynote speakers and workshop programme for its 6th Annual Drug Discovery Conference.
Tuesday, August 14, 2012
ELRIG Announces Speaker Programme for Drug Discovery 2012 Conference
The 6th Annual Drug Discovery Conference, in collaboration with SLAS, will be held at Manchester Central Convention Complex on 5th – 6th September 2012.
Monday, April 30, 2012
ELRIG Drug Discovery 2011
The 5th ELRIG Drug Discovery show, held in Manchester on 7 & 8th September 2011, attracted 1,125 delegates and a record number of exhibitors.
Thursday, September 22, 2011
ELRIG Drug Discovery 2010 - Free Online Registration – Book you place Now
ELRIG, the European Laboratory Robotics Interest Group, are proud to announce that FREE registration to Drug Discovery 2010 is open online. Drug Discovery 2010 will be held at the Ricoh Arena, Coventry, UK on 1st and 2nd September 2010.
Monday, August 02, 2010
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!